Correlation Between Memphis Pharmaceuticals and Fawry For

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Fawry For at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Fawry For into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and Fawry For Banking, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Fawry For and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Fawry For. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Fawry For.

Diversification Opportunities for Memphis Pharmaceuticals and Fawry For

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Memphis and Fawry is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Fawry For Banking in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fawry For Banking and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Fawry For. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fawry For Banking has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Fawry For go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Fawry For

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 3.7 times more return on investment than Fawry For. However, Memphis Pharmaceuticals is 3.7 times more volatile than Fawry For Banking. It trades about 0.12 of its potential returns per unit of risk. Fawry For Banking is currently generating about -0.01 per unit of risk. If you would invest  3,705  in Memphis Pharmaceuticals on September 27, 2024 and sell it today you would earn a total of  1,493  from holding Memphis Pharmaceuticals or generate 40.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  Fawry For Banking

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Fawry For Banking 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fawry For Banking has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Fawry For is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals and Fawry For Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and Fawry For

The main advantage of trading using opposite Memphis Pharmaceuticals and Fawry For positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Fawry For can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fawry For will offset losses from the drop in Fawry For's long position.
The idea behind Memphis Pharmaceuticals and Fawry For Banking pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges